We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Success With De Novo Pathway Tied to Strong Presubmission Process
Success With De Novo Pathway Tied to Strong Presubmission Process
Makers of low and moderate risk devices can now use the FDA’s de novo pathway to gain approval without first filing for 510(k) clearance – and the FDA wants to encourage more devicemakers to take advantage of the pathway.